Ossur Hf : Össur Reporting Calendar 2016

Report this content
Announcement from Össur hf. No. 50/2015
Reykjavík, 17 December 2015

 

Össur Reporting Calendar 2016

Following are the expected dates for publication of financial results for 2016:

1st Quarter - 27 April 2016

2nd Quarter - 21 July 2016

3rd Quarter - 26 October 2016

4th Quarter and Consolidated Financial Statements - 7 February 2017

Annual General Meeting - 9 March 2017

 

Further information:

Óskar Márus Daðason, IR Manager           Tel: +1 949 220 4550

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at our web-site: www.ossur.com/investormailings.

About Össur

Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations.  Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy.  A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com

Forward-Looking Statements

This press release includes "forward-looking statements" which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Össur hf. undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.

HUG#1974664

Subscribe